Uterine Fibroids Linked To Women’s Heart Disease Risk: An analysis of data from more than 2.6 million women, published in the Journal of the American Heart Association, associated uterine fibroids with an 81% higher risk of heart disease over 10 years. Women younger than age 40 had the highest risk. Researchers said from 20% to 80% of women could develop fibroids by age 50.
For decades, dreary winters have sent people running to the tanning salon to get that summery golden glow. In the United States (U.S.) alone, estimates suggest 30 million people get bronzed each year. However, tanning beds are also potent carcinogens, since their intense doses of Ultraviolet (UV) rays can penetrate skin cells and cause DNA mutations. Now, scientists have determined just how dangerous tanning salons can be.
Lumos Labs has obtained a clearance from the FDA for its popular Lumosity brain training platform, greenlighting a version of it to be marketed as a prescription digital therapeutic for adults with Attention – Deficit/Hyperactivity Disorder (ADHD) for the first time.
The United States Food and Drug Administration (FDA) has approved its first at-home, nondrug therapy for depression, with a wearable brain stimulation headset developed by Flow Neuroscience (Flow).
A parent’s determination leads to rare disease treatment for her son: Maxwell Freed, an 8-year-old with the extremely rare neurodevelopmental disorder known as “SLC6A1”, has become the first person in the world to receive a treatment for it, thanks to his mother, Amber Freed, who spent years fundraising and pushing Scientists and Regulators to move the research forward. While a repurposed FDA-approved drug helped buy time early on, her advocacy helped drive the creation and testing of a new gene therapy that received FDA approval in June 2025. Maxwell received the one-time treatment in September 2025 and is now in rehabilitation and showing signs of progress.
Drastic overhauls of U.S. vaccine regulations proposed by top United States (US) Food and Drug Administration (FDA) official Vinay Prasad, M.D., have drawn harsh pushback from 12 former commissioners of the Agency.
Medical device makers must comply with the U.S. Food and Drug Administration’s (FDA) Quality Management System Regulation (QMSR) after the rule took effect on Monday, 02 FEB 2026. Additionally, FDA inspections of device facilities will no longer be conducted under the prior Quality System Inspection Technique (QSIT) and instead will be carried out in accordance with a new Compliance Program Manual.
The U.S. Department of Health and Human Services (DHHS) and the U.S. Department of State announced the United States’ completion of its withdrawal from the World Health Organization (WHO) due to the organization’s mishandling of the COVID-19 pandemic that arose out of Wuhan, China, its failure to adopt urgently needed reforms, and its inability to demonstrate independence from the inappropriate political influence of WHO member states.